Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin (Halaven) in metastatic breast cancer
2012-004463-41Phase 2Terminated
- Sponsor
- MEDSIR
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by MEDSIR. Started Feb 2013; status: terminated.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-004463-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004463-41.